Skip to main content
SpringerLink
Log in

Modulation of MK-801 response by dopaminergic agents in mice

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Various doses of the non-competitive N-methyl-d-aspartate (NMDA) receptor antagonists, MK-801 (0.1–0.5 mg/kg) and ketamine (2.5–10 mg/kg), produced a dose-dependent increase in stereotypic behaviour in naive mice. MK-801 (0.1 mg/kg) and ketamine (2.5 mg/kg) potentiated the stereotypic response of apomorphine (0.1–0.5 mg/kg) in mice pretreated with reserpine (5 mg/kg, 24 h prior) and alpha-methyl-p-tyrosine (150 mg/kg, 1 h prior) but not in naive mice. SKF 38393, a D1 dopamine agonist, enhanced whereas B-HT 920, a D2 dopamine agonist, reduced the stereotypic response of MK-801 in naive mice. The response of MK-801 was blocked by pretreatment with haloperidol (0.5 mg/kg), molindone (2.5 mg/kg), clozapine (7.5 mg/kg) and SCH 23390 (0.1 mg/kg). The present data suggest involvement of endogenous DA transmission in the stimulant action of non-competitive NMDA antagonists in mice. Dopamine D1 and D2 receptor stimulation, respectively, exert opposing effects on the behavioural expression of MK-801 in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anden N-E, Carlsson A, Dahlstrom A, Fuxe K, Hillarp NA, Larsson K (1964) Demonstration and mapping out of nigroneostriatal dopamine neurons. Life Sci 3:523–530

    Article  Google Scholar 

  • Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-d-aspartate. Br J Pharmacol 79:565–575

    Google Scholar 

  • Carlsson M, Carlsson A (1989a) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221–226

    Article  PubMed  Google Scholar 

  • Carlsson M, Carlsson A (1989b) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77:65–71

    Article  PubMed  Google Scholar 

  • Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo(a,d) cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2:135–145

    Article  Google Scholar 

  • Clow DW, Jhamandas K (1989) Characterization ofl-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J Pharmacol Exp Ther 248:722–728

    PubMed  Google Scholar 

  • Costall B, Naylor RJ (1973) On the mode of action of apomorphine. Eur J Pharmacol 21:350–361

    Article  PubMed  Google Scholar 

  • Crowder JM, Bradford HF (1987) Inhibitory effects of noradrenaline and dopamine on calcium influx and neurotransmitter glutamate release in mammalian brain slices. Eur J Pharmacol 143:343–352

    Article  PubMed  Google Scholar 

  • Cuenod M, Beaudet A, Canzek V, Streit P, Reubi JC (1981) Glutamatergic pathways in the pigeon and rat brain. Adv Biochem Psychopharmacol 27:57–68

    PubMed  Google Scholar 

  • Dawbarn D, Pycock CJ (1981) Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic cell bodies in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 318:199–204

    Google Scholar 

  • Deutch AY, Tam S-Y, Freeman AS, Bowers MB Jr, Roth RH (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol 134:257–264

    Article  PubMed  Google Scholar 

  • Ellenbroek BA, Artz MT, Cools AR (1991) The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103–108

    Article  PubMed  Google Scholar 

  • Fallon JH, Moore RY (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545–580

    Article  PubMed  Google Scholar 

  • Fessler RG, Sturgeon RD, Meltzer HY (1979) Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxy-dopamine-induced lesions of the substantia nigra. Life Sci 24:1281–1288

    Article  PubMed  Google Scholar 

  • French ED, Pilapil C, Quirion R (1985) Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. Eur J Pharmacol 116:1–9

    Article  PubMed  Google Scholar 

  • Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166:359–366

    Article  PubMed  Google Scholar 

  • Hsu WH, Schaffer DD, Dyer DC (1986) The emetic effect of B-HT 920 and apomorphine in dogs: antagonism by haloperidol. Life Sci 39:1021–1026

    Article  PubMed  Google Scholar 

  • Iorio LC, Barnett A, Leitz FH, House VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468

    PubMed  Google Scholar 

  • Javitt DC (1987) Negative symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9:12–35

    PubMed  Google Scholar 

  • Liljequist S, Ossowska K, Grabowska-Anden M, Anden N-E (1991) Effect of the NMDA receptor antagonist, MK-801 on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55–61

    Article  PubMed  Google Scholar 

  • Maura G, Giardi A, Raiteri M (1988) Release regulating D2 dopamine receptors located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther 247:680–684

    PubMed  Google Scholar 

  • Mehta AK, Ticku MK (1990) Role of N-methyl-d-aspartate (NMDA) receptors in experimental catalepsy in rats. Life Sci 46:37–42

    Article  PubMed  Google Scholar 

  • Mitchell PR, Doggett NS (1980) Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs. Life Sci 26:2073–2081

    Article  PubMed  Google Scholar 

  • Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxy dopamine model of Parkinson's disease. Eur J Pharmacol 182:611–612

    Article  PubMed  Google Scholar 

  • Roberts PJ, McBean GJ, Sharif NA, Thomas EM (1982) Striatal glutamatergic function: modifications following specific lesions. Brain Res 235:83–91

    Article  PubMed  Google Scholar 

  • Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229–313

    PubMed  Google Scholar 

  • Setler PE, Sarau HM, Zircle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419–430

    Article  PubMed  Google Scholar 

  • Snell LD, Johnson KM (1985) Antagonism of N-methyl-d-aspartate induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behaviour. J Pharmacol Exp Ther 235:50–57

    PubMed  Google Scholar 

  • Snell LD, Yi S-J, Johnson KM (1988) Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA- induced norepinephrine release. Eur J Pharmacol 145:223–226

    Article  PubMed  Google Scholar 

  • Snyder SH (1980) Phencyclidine. Nature 285:355–356

    Article  PubMed  Google Scholar 

  • Spencer NJ (1976) Antagonism of cortical excitation of striatal neurones by glutamic acid diethyl ester: evidence for glutamic acid as an excitatory transmitter in the rat striatum 102:91–101

  • Verma A, Kulkarni SK (1991) Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice. Ind J Exp Biol 29:123–126

    Google Scholar 

  • Walker JM, Bowen WD, Walker FO, Matsumoto RR, Costa BD, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355–402

    PubMed  Google Scholar 

  • Zukin SR, Zukin RS (1979) Specific [3H]-phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372–5376

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology Division, Department of Pharmaceutical Sciences, Panjab University, 160014, Chandigarh, India

    Anita Verma & S. K. Kulkarni

Authors
  1. Anita Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verma, A., Kulkarni, S.K. Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107, 431–436 (1992). https://doi.org/10.1007/BF02245171

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245171

Key words

Search

Navigation